Case · 03

Finding the product underneath the science

Defining the shared product model across a growing set of clinical and research capabilities.

Role
Design lead — product strategy
Timeline
2024 — present
Status
Ongoing
Tags
Product strategy · Platform design · Clinical & research software

As BrainSightAI expanded, the product risked becoming a collection of individual capabilities organised around disorders, algorithms and customer requests.

I helped define the common product model underneath them.

Two products, one shared review model.

The problem

The company was working across clinical brain mapping, functional metrics, tract metrics, normative comparison, longitudinal analysis, group research, TMS and DBS-related workflows, and stroke, TBI, dementia and surgical planning.

Each could become its own product. That would create duplicated workflows, inconsistent interaction models and a roadmap driven by the latest scientific capability rather than a coherent user model.

The strategic question

What remains the same across these use cases?

The answer was not a particular disorder or algorithm. It was the user’s need to understand a derived result, compare it with trusted context, adjust how it was inspected and reach a conclusion.

This led to a shared model:

Confirm → Modify → Conclude

How it shaped the portfolio

VoxelBox

A guardrailed clinical product designed for repeatable review, reporting and decision support. The interface needed to limit ambiguity and make the approved workflow clear.

VoxelVault

A more exploratory research product supporting group analysis, longitudinal change, normative comparison and advanced metrics. The interface could expose greater flexibility because the goal was investigation rather than routine clinical reporting.

Where the two products diverge — guardrails in clinical, flexibility in research.

My contribution

I used this model to connect seemingly separate feature requests, distinguish shared foundations from product-specific workflows, clarify where clinical guardrails were necessary, create a more coherent direction for the viewer, support prioritisation across clinical and research use cases, and give teams a common language for discussing the roadmap.

Why this work matters

Scientific companies often have many valuable capabilities before they have a clear product structure.

Design can help determine which capabilities belong together, which require different levels of freedom and what the user is actually trying to accomplish across them.